CSIMarket
 
Inogen Inc   (NASDAQ: INGN)
 

Inogen Inc's Suppliers Performance

INGN's Supply Chain




 
INGN Costs vs Sales of Suppliers Growth Inogen Inc recorded an increase in cost of sales by 1.72 % year on year, sequentially cost of sales grew by 9.66 % in Q2.

More on INGN Suppliers



Inogen Inc recorded increase in cost of sales by 1.72 % year on year, sequentially cost of sales grew by 9.66 % in Q2.

More on INGN Suppliers




Inogen Inc's Comment on Supply Chain


Since 2004, the company has developed its oxygen concentrator manufacturing by initially outsourcing most processes and subsequently bringing assembly of compressors, sieve beds, and concentrators in-house to enhance quality and reduce costs. For European sales, a contract manufacturer in the Czech Republic manages high-volume products and repairs. Assembly operations are maintained in Plano, Texas, while the Simeox device is manufactured in Montpelier, France. The company employs lean manufacturing and sources components from third-party manufacturers, occasionally relying on single suppliers for key components to control costs and quality, which introduces supply risks. To address these risks, second-sourcing initiatives have been implemented to qualify alternative suppliers and reduce costs. The company operates a design facility in Goleta, California, which is registered with the FDA and certified to ISO 13485:2016 by BSI. Its Quality Assurance and Regulatory Affairs departments oversee quality management, supplier performance, and internal audits to support continuous improvement.

Inogen Inc's Comment on Supply Chain


Since 2004, the company has developed its oxygen concentrator manufacturing by initially outsourcing most processes and subsequently bringing assembly of compressors, sieve beds, and concentrators in-house to enhance quality and reduce costs. For European sales, a contract manufacturer in the Czech Republic manages high-volume products and repairs. Assembly operations are maintained in Plano, Texas, while the Simeox device is manufactured in Montpelier, France. The company employs lean manufacturing and sources components from third-party manufacturers, occasionally relying on single suppliers for key components to control costs and quality, which introduces supply risks. To address these risks, second-sourcing initiatives have been implemented to qualify alternative suppliers and reduce costs. The company operates a design facility in Goleta, California, which is registered with the FDA and certified to ISO 13485:2016 by BSI. Its Quality Assurance and Regulatory Affairs departments oversee quality management, supplier performance, and internal audits to support continuous improvement.







INGN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Inogen Inc 137.93 354.30 -24.60 753
SUBTOTAL 0.00 0.00 0.00 -


Sources: Inogen Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Inogen Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.